Suppr超能文献

在新发帕金森病中,MDS-UPDRS 对轻度疾病的敏感性是否高于 UPDRS?

Does MDS-UPDRS Provide Greater Sensitivity to Mild Disease than UPDRS in De Novo Parkinson's Disease?

作者信息

Tosin Michelle H S, Stebbins Glenn T, Comella Cynthia, Patterson Charity G, Hall Deborah A

机构信息

Department of Nursing Fluminense Federal University Niteroi Brazil.

Department of Neurological Sciences Rush University Medical Center Chicago Illinois USA.

出版信息

Mov Disord Clin Pract. 2021 Sep 6;8(7):1092-1099. doi: 10.1002/mdc3.13329. eCollection 2021 Oct.

Abstract

BACKGROUND

The Movement Disorder Society revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS) was designed to be more sensitive to mild motor severity than the Unified Parkinson's Disease Rating Scale (UPDRS).

OBJECTIVE

To test whether MDS-UPDRS Part III items provide increased sensitivity to mild motor severity when compared to the same items of the UPDRS in de novo PD patients.

METHOD

Using a sample of 129 de novo PD patients assessed at one time point simultaneously with both scales, we compared the scale's scores on the 17 items measuring the same motor function. The scaling anchors for the MDS-UPDRS were Slight, Mild, Moderate and Severe, and for the UPDRS were Mild, Moderate, Severe and Marked. Using Classical Test Theory (CTT) we compared the distributions of the scaling anchors from the individual items. Using Item Response Theory (IRT), we examined the sensitivity of the scaling anchors from each scale to the latent-trait measurement of overall parkinsonian motor severity.

RESULTS

There was 2193 observations of individual scaling anchors from the 17 items in both scales. The CTT approach revealed frequent floor effects with only the item assessing Gait demonstrating a significance difference in the scaling distribution between the scales ( = 0.005). The IRT analyses revealed similar levels of sensitivity to the latent trait of PD motor function.

CONCLUSION

These results do not support increased sensitivity of MDS-UPDRS over the UPDRS for assessing mild motor severity in de novo PD patients, with significant difference in the scaling only for the item assessing gait.

摘要

背景

运动障碍学会对统一帕金森病评定量表(MDS-UPDRS)的修订旨在比统一帕金森病评定量表(UPDRS)对轻度运动严重程度更敏感。

目的

测试与新发帕金森病(PD)患者的UPDRS相同项目相比,MDS-UPDRS第三部分项目对轻度运动严重程度是否具有更高的敏感性。

方法

使用129例新发PD患者的样本,在同一时间点同时使用这两种量表进行评估,我们比较了两种量表在测量相同运动功能的17个项目上的得分。MDS-UPDRS的分级锚定为轻微、轻度、中度和重度,UPDRS的分级锚定为轻度、中度、重度和显著。使用经典测试理论(CTT),我们比较了各个项目分级锚定的分布。使用项目反应理论(IRT),我们检查了每个量表分级锚定对帕金森病总体运动严重程度潜在特质测量的敏感性。

结果

两种量表的17个项目共有2193个个体分级锚定观察值。CTT方法显示频繁出现地板效应,只有评估步态的项目在量表之间的分级分布上显示出显著差异(P = 0.005)。IRT分析显示对PD运动功能潜在特质的敏感性水平相似。

结论

这些结果不支持MDS-UPDRS在评估新发PD患者轻度运动严重程度方面比UPDRS具有更高的敏感性,仅评估步态的项目在分级上有显著差异。

相似文献

1
Does MDS-UPDRS Provide Greater Sensitivity to Mild Disease than UPDRS in De Novo Parkinson's Disease?
Mov Disord Clin Pract. 2021 Sep 6;8(7):1092-1099. doi: 10.1002/mdc3.13329. eCollection 2021 Oct.
7
Predicting the Progression of Parkinson's Disease MDS-UPDRS-III Motor Severity Score from Gait Data using Deep Learning.
Annu Int Conf IEEE Eng Med Biol Soc. 2021 Nov;2021:249-252. doi: 10.1109/EMBC46164.2021.9630769.
8
Relationship between the non-motor items of the MDS-UPDRS and Quality of Life in patients with Parkinson's disease.
J Neurol Sci. 2015;353(1-2):87-91. doi: 10.1016/j.jns.2015.04.013. Epub 2015 Apr 17.
9
Item Response Theory Analysis of the MDS-UPDRS Motor Examination: Tremor vs. Nontremor Items.
Mov Disord. 2020 Sep;35(9):1587-1595. doi: 10.1002/mds.28110. Epub 2020 May 29.
10

引用本文的文献

1
Understanding the progression of Parkinson's disease: a review.
BMJ Neurol Open. 2025 Sep 8;7(2):e001215. doi: 10.1136/bmjno-2025-001215. eCollection 2025.
4
Characterizing Disease Progression in Parkinson's Disease from Videos of the Finger Tapping Test.
IEEE Trans Neural Syst Rehabil Eng. 2024;32:2293-2301. doi: 10.1109/TNSRE.2024.3416446. Epub 2024 Jun 26.
5
Validation of the Kazakh version of the movement disorder Society-Unified Parkinson's disease rating scale.
Clin Park Relat Disord. 2024 Jan 6;10:100232. doi: 10.1016/j.prdoa.2024.100232. eCollection 2024.
7
Neurophysiological Predictors of Response to Medication in Parkinson's Disease.
Front Neurol. 2021 Nov 16;12:763911. doi: 10.3389/fneur.2021.763911. eCollection 2021.

本文引用的文献

1
Integrated Care in Parkinson's Disease: A Systematic Review and Meta-Analysis.
Mov Disord. 2020 Sep;35(9):1509-1531. doi: 10.1002/mds.28097. Epub 2020 Jun 29.
2
Item Response Theory Analysis of the MDS-UPDRS Motor Examination: Tremor vs. Nontremor Items.
Mov Disord. 2020 Sep;35(9):1587-1595. doi: 10.1002/mds.28110. Epub 2020 May 29.
3
The Challenge of Disease-Modifying Therapies in Parkinson's Disease: Role of CSF Biomarkers.
Biomolecules. 2020 Feb 19;10(2):335. doi: 10.3390/biom10020335.
7
9
Old and new challenges in Parkinson's disease therapeutics.
Prog Neurobiol. 2017 Sep;156:69-89. doi: 10.1016/j.pneurobio.2017.04.006. Epub 2017 Apr 27.
10
Precision medicine for disease modification in Parkinson disease.
Nat Rev Neurol. 2017 Feb;13(2):119-126. doi: 10.1038/nrneurol.2016.196. Epub 2017 Jan 20.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验